OrbusNeich Medical Group Holdings (FRA:Q8T) Revenue : €154.7 Mil (TTM As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is OrbusNeich Medical Group Holdings Revenue?

OrbusNeich Medical Group Holdings's revenue for the six months ended in Jun. 2024 was €73.3 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2024 was €154.7 Mil. OrbusNeich Medical Group Holdings's Revenue per Share for the six months ended in Jun. 2024 was €0.09. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €0.19.

During the past 12 months, the average Revenue per Share Growth Rate of OrbusNeich Medical Group Holdings was 1.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 20.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 6 years, OrbusNeich Medical Group Holdings's highest 3-Year average Revenue per Share Growth Rate was 20.30% per year. The lowest was 14.80% per year. And the median was 17.55% per year.

OrbusNeich Medical Group Holdings Revenue Historical Data

The historical data trend for OrbusNeich Medical Group Holdings's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrbusNeich Medical Group Holdings Revenue Chart

OrbusNeich Medical Group Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Revenue

Get a 7-Day Free Trial

72.72

103.07

129.16

141.09

156.71

OrbusNeich Medical Group Holdings Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Revenue	Get a 7-Day Free Trial					64.17	75.14	66.44	73.31	81.35

Competitive Comparison of OrbusNeich Medical Group Holdings's Revenue

For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OrbusNeich Medical Group Holdings's Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's Revenue distribution charts can be found below:

* The bar in red indicates where OrbusNeich Medical Group Holdings's Revenue falls into.

Save Embed

;

Save Embed

;

OrbusNeich Medical Group Holdings Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €154.7 Mil.

OrbusNeich Medical Group Holdings (FRA:Q8T) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

OrbusNeich Medical Group Holdings Revenue Related Terms

Thank you for viewing the detailed overview of OrbusNeich Medical Group Holdings's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

OrbusNeich Medical Group Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrbusNeich Medical Group Holdings Ltd (FRA:Q8T) » Definitions » Revenue

Comparable Companies

Traded in Other Exchanges

06929:Hong Kong

Address

3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG

Website

https://www.orbusneich.com

OrbusNeich Medical Group Holdings Ltd is a China-based medical device maker of endovascular interventional instruments with majority reach. It launched its first research base in 2001 and was listed on the Hong Kong Exchange in 2022. As of 2023, OrbusNeich's majority revenue segment by geography is Japan with 24.7% of total revenue followed by Europe, the Middle East, and Africa, with 23.6% of total revenue. The Asia-Pacific region and the United States make up the balance. Its product segment is coronary interventional medical devices, such as scoring balloons, non-compliant balloons, or stents, together representing 82.7% of its total revenue.

OrbusNeich Medical Group Holdings Headlines

No Headlines